TheMercantilist Posted - 3 hours ago

$BMY will go to 40 by June then bounce to 45 at earnings

Kain_C64 Posted - 3 hours ago

$BMY @patientshark When you gonna chomp on this?

Cj_is_koool Posted - 4 hours ago

$BMY generational wealth. cant wait for September PDUFA

Stocknut62 Posted - 4 hours ago

$BMY what a POS this stock.. approaching a 10 year low in a bull market..probably heading into the 30s.. no impetus to go higher

Wa115treetgrinder Posted - 6 hours ago

$BMY every week is a new 52w low. 🤦

mickeyp_ Posted - 6 hours ago

$BMY CHEAP STOCK

BlackCatTrader Posted - 7 hours ago

$BMY Added a few today, too good to pass up here.

Trending__Now Posted - 7 hours ago

$BMY Hopefully we can look back and find which institutional idiots sold. Honestly, in an industry of ego's someone is playing the dolt.

Briguy1 Posted - 7 hours ago

$BMY yea...didn't want to but I have to buy down here - healthy starter position and just sit and wait with that div that appears safe relative to the present and past history.

Wa115treetgrinder Posted - 8 hours ago

$BMY anyone know why are they down today?

gp1M Posted - 8 hours ago

$BMY Full account long

Strongbagholder Posted - 8 hours ago

$CSCO $INTC $BMY 100 each 🤝 🤞

faucis_picks Posted - 8 hours ago

$BMY short

Trending__Now Posted - 8 hours ago

$BMY I am such a nice person. Some institution had to sell to me at 43.55 and I was full of compassion. Sometimes I just amaze myself at what a wonderful person I am.

johnmilnes Posted - 9 hours ago

$BMY Time to add a few more

dloeb Posted - 9 hours ago

$BMY in lock step together again with selling pressure to these big mega caps $PFE

Thesis_Alexander Posted - 9 hours ago

$BMY https://www.linkedin.com/posts/vikramshanbhag_label-expansion-remans-a-key-goal-for-any-activity-7198370223316492288-riIz?utm_source=share&utm_medium=member_desktop

STOCKPICKERTRADER Posted - 9 hours ago

@Trending__Now picking up shares here as well - gltu $BMY

Trending__Now Posted - 11 hours ago

$BMY Slept in. Wow. Got my 43.77 alarm. I'll be picking up some calls.

SPG565 Posted - 11 hours ago

$BMY Sold more Puts. 👍

Zonata Posted - 12 hours ago

$BMY got some BMY for bottom play. IMO this will bounce back. I can hold 2-3 years no problem.

dloeb Posted - 12 hours ago

@STOCKPICKERTRADER agree and also like $PRGO $PFE $BABA $BMY at these levels too

STOCKPICKERTRADER Posted - 12 hours ago

$BMY another mega cap solid pharma with a strong dividend and plenty of upside potential. Just keep adding on dips to them retirement accounts!

HeyDuggee Posted - 15 hours ago

$BMY $BIO $BSX $ENOV

Trending__Now Posted - 1 day ago

$BMY I may or may not have mentioned this here, but y'all might wanna DD CAPR and consider picking up some shares before it pops into 2025. You do you.

Trending__Now Posted - 1 day ago

$BMY @Thesis_Alexander Back in late 2020, https://news.bms.com/news/details/2020/Bristol-Myers-Squibb-to-Acquire-MyoKardia-for-13.1-Billion-in-Cash/default.aspx Mavacamten is FDA approved. Expected 2025 revenue between $900-$1B, 2026 $1.6B - $2B, and roughly $2B per year after that. Guesstimate. We're at the 10 year lows...again. I wouldn't exactly call the institutions selling geniuses. This is how retail wins. Buy the institutional selling and collect the dividend in the meantime. Win-win.

Thesis_Alexander Posted - 1 day ago

$BMY The following excerpt is from the BofA conference, conducted on May 15, 2024, and might be helpful in attempting to forecast Q2 2024 revenues from the growth portfolio. "So as we're looking at that business, we're looking at a double-digit, about 10% growth, Q1 to Q2 sequentially for Sotyktu and Zeposia, and Orencia is probably going to be a single digit sequential growth for Q2." Sotyktu (Deucravacitinib) - Q1 (24) revenues $44,000,000 ~ Q2 (24) revenues $48,400,000 Zeposia (Azanimod) - Q1 (24) revenues $110,000,000 ~ Q2 (24) revenues $121,400,000 Orencia (Abatacept) - Q1 (24) revenues $798,000,000 ~ Q2 (24) revenues $830,000,000

trigger_finger Posted - 2 days ago

$BMY I need a new shovel for my Ira account. It broke loading shares at this level.

Thesis_Alexander Posted - 3 days ago

$BMY "Cantor expects that Bristol-Myers Squibb Co (NYSE:BMY), which acquired Karuna Therapeutics’ KarXT, will likely come to market before AbbVie’s antipsychotic emraclidine and become the leading drug." https://markets.businessinsider.com/news/stocks/abbvie-is-successfully-positioned-to-absorb-humira-biosimilar-erosion-analyst-1033400477

Thesis_Alexander Posted - 3 days ago

$BMY Jenny Talkington discusses the basis of the decision to acquire shares of Bristol Myers Squibb on CNBC's Halftime Report. https://www.msn.com/en-us/money/news/trade-tracker-goldman-sachs-bristol-myers-and-tjx/vi-BB1mA3xw?ocid=socialshare